279 related articles for article (PubMed ID: 33198125)
1. Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC).
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Kalinski P; Endo I; Takabe K
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198125
[TBL] [Abstract][Full Text] [Related]
2. CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.
Oshi M; Asaoka M; Tokumaru Y; Yan L; Matsuyama R; Ishikawa T; Endo I; Takabe K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971948
[TBL] [Abstract][Full Text] [Related]
3. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival.
Wu R; Oshi M; Asaoka M; Huyser MR; Tokumaru Y; Yamada A; Yan L; Endo I; Ishikawa T; Takabe K
Am J Cancer Res; 2022; 12(2):744-762. PubMed ID: 35261799
[TBL] [Abstract][Full Text] [Related]
5. Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients.
Oshi M; Newman S; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
J Immunol Res; 2020; 2020():5618786. PubMed ID: 33457427
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer.
Oshi M; Patel A; Wu R; Le L; Tokumaru Y; Yamada A; Yan L; Matsuyama R; Ishikawa T; Endo I; Takabe K
NPJ Breast Cancer; 2022 Aug; 8(1):92. PubMed ID: 35945417
[TBL] [Abstract][Full Text] [Related]
7. Discrepancy in Response of Mouse Dendritic Cells against BCG: Weak Immune Effects of Plasmacytoid Dendritic Cells Compared to Classical Dendritic Cells despite the Uptake of Bacilli.
Meng C; Liu J; Kang X; Xu Z; Xu S; Li X; Pan Z; Chen X; Jiao X
Trop Med Infect Dis; 2023 Feb; 8(3):. PubMed ID: 36977141
[TBL] [Abstract][Full Text] [Related]
8. Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC).
Tokumaru Y; Oshi M; Murthy V; Tian W; Yan L; Angarita FA; Nagahashi M; Matsuhashi N; Futamura M; Yoshida K; Miyoshi Y; Takabe K
Am J Cancer Res; 2021; 11(11):5743-5755. PubMed ID: 34873491
[TBL] [Abstract][Full Text] [Related]
9. High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer.
Oshi M; Angarita FA; Tokumaru Y; Yan L; Matsuyama R; Endo I; Takabe K
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371179
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells--at the front-line of pathogen attack.
McCullough KC; Ruggli N; Summerfield A
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):7-15. PubMed ID: 19036457
[TBL] [Abstract][Full Text] [Related]
11. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
Okano M; Oshi M; Butash AL; Katsuta E; Tachibana K; Saito K; Okayama H; Peng X; Yan L; Kono K; Ohtake T; Takabe K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461932
[TBL] [Abstract][Full Text] [Related]
12. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.
Sisirak V; Faget J; Gobert M; Goutagny N; Vey N; Treilleux I; Renaudineau S; Poyet G; Labidi-Galy SI; Goddard-Leon S; Durand I; Le Mercier I; Bajard A; Bachelot T; Puisieux A; Puisieux I; Blay JY; Ménétrier-Caux C; Caux C; Bendriss-Vermare N
Cancer Res; 2012 Oct; 72(20):5188-97. PubMed ID: 22836755
[TBL] [Abstract][Full Text] [Related]
13. Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Oshi M; Asaoka M; Tokumaru Y; Angarita FA; Yan L; Matsuyama R; Zsiros E; Ishikawa T; Endo I; Takabe K
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33086518
[TBL] [Abstract][Full Text] [Related]
14. Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8
Ji Y; Heng Y; Zhu X; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
Transl Oncol; 2024 Jul; 45():101936. PubMed ID: 38678970
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cell development.
Shortman K; Sathe P; Vremec D; Naik S; O'Keeffe M
Adv Immunol; 2013; 120():105-26. PubMed ID: 24070382
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of distribution and quantity of dendritic cells subtypes in hyperplastic thymus in patients with myasthenia gravis].
Huang H; Chen P; Ou CY; Qiu L; Lin ZZ; Huang ZD; Liu WB
Zhonghua Yi Xue Za Zhi; 2017 May; 97(19):1463-1468. PubMed ID: 28535636
[No Abstract] [Full Text] [Related]
17. ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer.
Wang X; Li Y; Fu J; Zhou K; Wang T
Pharmgenomics Pers Med; 2021; 14():1425-1440. PubMed ID: 34785930
[TBL] [Abstract][Full Text] [Related]
18. Classical swine fever virus induces activation of plasmacytoid and conventional dendritic cells in tonsil, blood, and spleen of infected pigs.
Jamin A; Gorin S; Cariolet R; Le Potier MF; Kuntz-Simon G
Vet Res; 2008; 39(1):7. PubMed ID: 18073094
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: B220+CCR9- dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells.
Segura E; Wong J; Villadangos JA
J Immunol; 2009 Aug; 183(3):1514-7. PubMed ID: 19570827
[TBL] [Abstract][Full Text] [Related]
20. Triple negative breast cancer - prognostic role of immune-related factors: a systematic review.
Stovgaard ES; Nielsen D; Hogdall E; Balslev E
Acta Oncol; 2018 Jan; 57(1):74-82. PubMed ID: 29168430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]